Claim Missing Document
Check
Articles

Found 14 Documents
Search

Pemberdayaan Apoteker Menghadapi Peluang dan Tantangan Pandemi Covid-19 dalam Pengembangan Produk Herbal Imunomodulator Kusumawati, Idha; Yuda, Ana; Hermansyah, Andi; Rullyansyah, Subhan
Humanism : Jurnal Pengabdian Masyarakat Vol 3 No 2 (2022): Agustus
Publisher : Universitas Muhammadiyah Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.30651/hm.v3i2.12902

Abstract

Pada Maret tahun 2020, WHO telah menyatakan covid-19 merupakan pandemi global. Hal ini berdampak kita harus berdamai dan menerima kondisi hidup bersama covid-19. Untuk dapat tetap bertahan dalam kondisi ini maka diperlukan berbagai penyesuaian yang salah satunya adalah meningkatkan kemampuan tubuh untuk mempertahankan diri. Seiring dengan meningkatnya kesadaran masyarakat akan pentingnya meningkatkan imunitas tubuh, salah satu yang juga meningkat adalah kebutuhan akan jamu atau produk herbal. Peningkatan ini menjadi peluang untuk pengembangan produk herbal/jamu Indonesia untuk imunomodulator yang memenuhi persyaratan keamanan dan mutu. Untuk itu dilaksanakan kegiatan Webinar Nasional ini sebagai kegiatan pengabdian masyarakat dengan tujuan untuk mengetahui dan mengukur tingkat pengetahuan para peserta mengenai tantangan dan peluang apoteker dalam menjalankan peranan prosfesinya di era pandemik COVID-19. Dari hasil kuesionair dapat diketahui bahwa peserta yang merupakan sejawat apoteker mampu melihat peluang untuk ikut berperan dalam menghadapi pandemi covid-19 dalam upaya pengembangan obat herbal untuk imunomodulator. Hal ini juga menunjukkan bahwa tujuan diselenggarakan webinar ini untuk pemberdayaan apoteker telah tercapai.
Balancing Need and Feasibility: Stakeholder Insights on Frequent Blood Glucose Monitoring in Indonesia Rinda, Agnes Christie; Athiyah, Umi; Hermansyah, Andi
Borneo Journal of Pharmacy Vol. 8 No. 3 (2025): Borneo Journal of Pharmacy
Publisher : Institute for Research and Community Services Universitas Muhammadiyah Palangkaraya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33084/bjop.v8i3.9848

Abstract

Patients with type 2 diabetes mellitus require regular evaluation of the medication's effectiveness and safety through blood glucose and HbA1c testing. This continuous monitoring is one of the primary roles of pharmacists in collaboration with physicians and supported by health insurance to examine the fluctuation patterns of blood glucose levels in response to diabetes medications. This study aimed to identify the need and feasibility of frequent blood glucose monitoring from the perspective of physicians, pharmacists, national health insurance officials, and diabetes patients. A qualitative study using semi-structured interviews was conducted in six Public Health Centers and seven pharmacies in Banjarmasin, Indonesia, from November 2022 to September 2023. A total of twenty-one respondents were included in this study. Data were tape-recorded, transcribed verbatim, and categorized using manual thematic content analysis. This study reveals that inappropriate patient conditions, irregular visits to Public Health Centers, patients' negative emotions, limitations in self-monitoring blood glucose, and lack of patients' knowledge create barriers to conducting monitoring of diabetes. On the other hand, the frequent blood glucose and HbA1c testing was supported by positive perceptions of the importance of testing, ease of access, and the active roles of physicians, pharmacists, and insurance officials. The barriers and facilitators of continuous diabetes medication monitoring are key factors that pharmacists, physicians, and insurance officials should consider to ensure that medication effectiveness and safety are monitored effectively.
Evaluation of the use, storage, and administration of narcotic drugs in pharmacies, hospitals, and community health centers: A literature review Maryono, Khaliq; Hermansyah, Andi; Wijaya, I Nyoman
Indonesian Journal of Health Services Vol. 2 No. 2 (2025): April - June
Publisher : Science Center Group

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.63202/ijhs.v2i2.95

Abstract

Background: The management of narcotic drugs in healthcare facilities requires strict control because these medicines have significant therapeutic benefits while also posing a high potential for misuse. Inappropriate practices in narcotic drug use, storage, and administration may increase the risk of medication errors and regulatory violations. Objective: This study aimed to evaluate the use, storage, and administration of narcotic drugs in pharmacies, hospitals, and community health centers through a comprehensive literature review. Methods: This study employed a systematic literature review design following the PRISMA 2020 guideline recommended by the EQUATOR Network. Literature searches were conducted in the Google Scholar database using keywords related to the evaluation of narcotic drug use, storage, and administration in healthcare facilities. Articles published between 2020 and 2024 were screened based on predefined inclusion and exclusion criteria. From 236 identified records, 21 articles met the eligibility criteria and were analyzed using a thematic synthesis approach. Results:The review showed that narcotic drug use in pharmacies was predominantly associated with codeine-containing preparations, whereas hospitals maintained a broader range of narcotic drugs including fentanyl, morphine, and pethidine. Community health centers mainly utilized methadone as part of methadone maintenance therapy programs. Storage compliance was generally high in pharmacies, while hospitals showed moderate variation and community health centers demonstrated more limitations in storage infrastructure. Administrative compliance was generally adequate, although several studies reported incomplete documentation of physician and patient information. Conclusion: Narcotic drug management across healthcare facilities is generally implemented according to regulatory standards, although variations in compliance remain in terms of use, storage, and administrative procedures. Strengthening monitoring systems, improving pharmaceutical workforce capacity, and ensuring consistent implementation of standard operating procedures are necessary to enhance the safety and accountability of narcotic drug management.
Profil Kepuasan Pasien terhadap Pelayanan Resep menggunakan SERVQUAL, Importance-Performance Analysis, dan Customer Satisfaction Index Berliana, Shefilla Mangestiti; Yuda, Ana; Rahem, Abdul; Zairina, Elida; Hermansyah, Andi; Nugraheni, Gesnita; Sulistyarini, Arie; Athiyah, Umi
MPI (Media Pharmaceutica Indonesiana) Vol. 8 No. 1 (2026): JUNE
Publisher : Fakultas Farmasi, Universitas Surabaya

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.24123/mpi.v8i1.8399

Abstract

Kepuasan pasien merupakan indikator penting mutu pelayanan kefarmasian, khususnya pada pelayanan resep se- bagai titik interaksi langsung antara apoteker dan pasien. Penelitian ini bertujuan menggambarkan profil kepuasan pasien terhadap pelayanan resep pada konteks apotek pendidikan berdasarkan lima dimensi SERVQUAL, yaitu tangibles, reliability, responsiveness, assurance, dan empathy, serta mengidentifikasi kesenjangan harapan-kinerja dan prioritas perbaikan layanan. Desain penelitian adalah observasional analitik dengan pendekatan cross-sectional. Pengumpulan data dilakukan pada Oktober- November 2024 terhadap 100 pasien yang menerima pelayanan resep dan memenuhi kriteria inklusi. Sampel dipilih dengan accidental sampling. Instrumen berupa kuesioner Likert 1-5 yang mengukur harapan (importance) dan kinerja (performance). Analisis data dilakukan menggunakan statistik deskriptif, analisis gap, Importance-Performance Analysis (IPA), dan Customer Satisfaction Index (CSI). Mayoritas responden adalah perempuan (66%), berusia 21-30 tahun (37%), berpendidikan SMA/SMK sederajat (58%), dan mahasiswa (57%). Rata-rata skor harapan sebesar 4,73 dan skor kinerja 4,52. Seluruh dimensi menunjuk- kan gap negatif, dengan gap terbesar pada reliability (-0,39) dan terkecil pada tangibles (-0,08). Nilai CSI keseluruhan 91,43% atau kategori sangat puas. Namun, beberapa indikator klinis seperti penjelasan cara penyimpanan obat (-1,18), efek samping obat (-0,83), dan waktu diskusi terapi (-0,36) masih menunjukkan kesenjangan yang bermakna secara praktis. Pasien secara umum sangat puas terhadap pelayanan resep, tetapi hasil gap dan IPA menunjukkan bahwa mutu layanan belum sepenuhnya memenuhi harapan pasien pada aspek informasi klinis dan komunikasi terapi. Perbaikan perlu diarahkan pada standardisasi konseling obat, penguatan peran apoteker, dan pengaturan waktu diskusi agar pelayanan resep tidak hanya dinilai memuaskan, tetapi juga mendukung keamanan penggunaan obat. Patient satisfaction is an important indicator of the quality of pharmaceutical services, particularly prescription services, where direct interaction between pharmacists and patients occurs. This study aimed to describe patient satisfaction with prescription services in a teaching pharmacy context based on the five SERVQUAL dimensions: tangibles, reliability, responsiveness, assurance, and empathy, and to identify expectation-performance gaps and service improvement priorities. This study used an analytical observational design with a cross-sectional approach. Data were collected from October to November 2024 among 100 patients receiving prescription services who met the inclusion criteria. Samples were obtained using accidental sampling. The instrument was a 1-5 Likert-scale questionnaire measuring expectations (importance) and performance. Data were analyzed using descriptive statistics, gap analysis, Importance-Performance Analysis (IPA), and the Customer Satisfaction Index (CSI). Most respondents were female (66%), aged 21-30 years (37%), had a senior high school/vocational school education (58%), and were students (57%). The overall mean expectation score was 4.73 and the mean performance score was 4.52. All SERVQUAL dimensions showed negative gaps, with the largest gap in reliability (-0.39) and the smallest in tangibles (-0.08). The overall CSI was 91.43%, indicating a very satisfied category. However, clinically important indicators such as drug storage instructions (-1.18), explanations of adverse effects (-0.83), and time for therapy discussion (-0.36) showed meaningful practical gaps. Patients were generally very satisfied with prescription services; however, the gap analysis and IPA findings indicate that service quality had not fully met patient expectations, particularly in clinical information and therapeutic communication. Improvement should focus on standardizing medication counseling, strengthening pharmacists roles, and allocating adequate discussion time so that prescrip- tion services are not only perceived as satisfactory but also support medication safety.